Anatomical Precision in modern techniques allows surgeons to address the exact pathology present in each individual case
The overall tolerability observed in clinical trials has been deemed acceptable
The MHRA said that between 2007 and October 2025 it received 1,296 Yellow Card reports of pancreatitis associated with these medicines, including 19 that involved a patient fatality and 24 reports of necrotising pancreatitis
Current anesthesia care guidance for diabetic patients taking GLP-1 agonists Lets examine the 2023 consensus-based practice guidelines published by the ASA regarding the anesthetic considerations of the GLP-1RAs: GLP-1 agonists are associated with many adverse effects, such as nausea, vomiting, delayed gastric emptying, and abdominal pain and bloating
Moving Forward In The GLP-1 Landscape In terms of dosage form, the single-dose format is projected to reach USD 413.34 billion by 2032 from USD 40.10 billion in 2024, at a CAGR of 33.9% during the forecast period
